Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
26.77%
↑ 154% above average
Average (14q)
-49.16%
Historical baseline
Range
High:80.61%
Low:-388.19%
Volatility
-953.6%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 26.77% |
| Q2 2025 | 4.63% |
| Q1 2025 | 8.16% |
| Q4 2024 | -73.90% |
| Q3 2024 | -0.62% |
| Q2 2024 | -43.87% |
| Q1 2024 | -45.38% |
| Q4 2023 | -10.38% |
| Q3 2023 | -3.34% |
| Q2 2023 | 80.61% |
| Q1 2023 | -3.28% |
| Q4 2022 | -388.19% |
| Q3 2022 | -104.35% |
| Q2 2022 | -184.26% |
| Q1 2022 | 0.00% |